开盘价:-- | 最高价:-- | 最低价:-- | 52周最高价:-- | 52周最低价:-- |
成交量:-- | 平均成交量:-- | 市值:-- | 市盈率:-- | 预期市盈率:-- |
每股收益:-- | 贝塔系数:-- | 股息:-- | 收益率:-- | 总股本:-- |
证券代码:trpx | 公司名称:Therapix Biosciences Ltd. | 公司中文简称: |
公司简介: Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Givatayim, Israel. |
||
公司网站: http://www.therapixbio.com |
||
公司地址: 4 Ariel Sharon Street HaShahar Tower 16th Floor Givatayim |